Compare Johnson & Johnson (JNJ) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Lowe`s Companies Inc — how do they compare? Johnson & Johnson trades at $259.35 (market cap $626.09B), while Lowe`s Companies Inc trades at $215.5 (market cap $124.06B). The key difference: Johnson & Johnson is far larger — about 5× Lowe`s Companies Inc's market cap, and Lowe`s Companies Inc pays the higher dividend (2.26%). Which is the better fit depends on your goals.
| JNJ | LOW | |
|---|---|---|
Market Cap | $626.09B | $124.06B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $287.39 |
52-Week Low | $172.78 | $201.92 |
Enterprise Value | $654.37B | $165.81B |
Dividend Yield | 2.06% | 2.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
Lowe's (LOW) trades at $218.84, down 2.02% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company has beaten earnings estimates for the last three quarters, with Q2 2026 results expected on August 19. Revenue declined to $83.67 billion in 2025, but net income margin remained healthy at 7.51%. A $1.25 dividend is scheduled for payment on August 5, 2026.
The outlook is supported by strong analyst consensus, with a $257.06 price target implying 17% upside. Risks include high debt levels and competitive pressures. Earnings growth in the professional segment is a key catalyst, but macroeconomic headwinds could challenge DIY sales momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
